Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study

Real-world safety of palbociclib in breast cancer patients in the United States: a new user cohort study

Abstract Background There is limited real-world safety information on palbociclib for treatment of advanced stage HR+/HER2- breast cancer. Methods We conducted a cohort study of breast cancer patients initiating palbociclib and fulvestrant from February 2015 to September 2017 using the HealthCore In...

Full description

Bibliographic Details
Main Authors: Daniel C. Beachler, Cynthia de Luise, Aziza Jamal-Allial, Ruihua Yin, Devon H. Taylor, Ayako Suzuki, James H. Lewis, James W. Freston, Stephan Lanes
Format: Article
Language:English
Published: BMC 2021-01-01
Series:BMC Cancer
Subjects:
Palbociclib
Safety
Real-world
Epidemiology
Acute liver injury
Online Access:https://doi.org/10.1186/s12885-021-07790-z

Internet

https://doi.org/10.1186/s12885-021-07790-z

Similar Items